Clinical Trial: Construction and Evaluaton of a Cllaborative Management Model for the Entre Prescription Circulaton Chain of hnovative Anticancer Medicines unde the Dual-Channel Policy (China)

China, Oct. 1 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction and Evaluaton of a Cllaborative Management Model for the Entre Prescription Circulaton Chain of hnovative Anticancer Medicines unde the Dual-Channel Policy'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133709

Registration Time: 2026/09/30

Type: Interventional study

Primary Sponsor: The Second Xiangya Hospital, Central South University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=346058

Published by HT Digital Content Services with permission from Health Daily Digest....